Related Experiment Video
Updated: Jun 8, 2026

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
12.2K
Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline.
R Vitorino1, S-P Hojjat2,3, C G Cantrell4
1Medical Imaging (R.V., S.-P.H., L.Z., R.I.A.), Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada rita.vitorino@sunnybrook.ca.
AJNR. American Journal of Neuroradiology
|May 21, 2016
Summary
Patients with relapsing-remitting multiple sclerosis (MS) show frontal cortical perfusion deficits. Cognitive impairment in MS is linked to more widespread hypoperfusion, independent of brain structure, suggesting perfusion is a key biomarker.
Area of Science:
- Neuroscience
- Medical Imaging
- Neurology
Background:
- Cortical dysfunction is common in multiple sclerosis (MS), often leading to cognitive impairment.
- Cerebral perfusion imaging can quantify this dysfunction.
Purpose of the Study:
- To identify differences in cerebral perfusion distribution in patients with relapsing-remitting MS (RRMS) with and without cognitive impairment.
- To compare these differences with healthy controls.
Main Methods:
- 39 RRMS patients (20 cognitively impaired, 19 non-impaired) and 19 healthy controls underwent neurocognitive testing and MRI.
- Voxel-based analysis was used to compare regional gray matter (GM) perfusion and volume.
Main Results:
- Reduced cerebral blood flow (CBF) and cerebral blood volume (CBV) were observed in the left middle frontal cortex in all MS patients.
- Cognitively impaired MS patients showed additional deficits in the left superior frontal gyrus and limbic regions.
- Reduced CBV was noted in the right middle frontal gyrus (cognitively impaired MS) and temporal gyrus (non-impaired MS) compared to controls.
Conclusions:
- Frontal cortical perfusion deficits are characteristic of RRMS.
- Widespread hypoperfusion in MS patients with cognitive impairment is independent of structural brain changes.
- Cerebral perfusion may serve as a valuable biomarker for cortical dysfunction and cognitive impairment in MS.
Related Concept Videos
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

